SCHEMBL14129786

SCHEMBL14129786

O=C1c2c(O)c(=O)c(-c3nccs3)cn2CCN1CCCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 1/20 0.39
PLA2G4A P47712 1/20 0.36
CES1 P23141 1/20 0.35
HDAC3 O15379 3/20 0.35
HDAC4 P56524 3/20 0.35
HDAC1 Q13547 3/20 0.35
HDAC7 Q8WUI4 3/20 0.35
HDAC2 Q92769 3/20 0.35
HDAC10 Q969S8 3/20 0.35
HDAC11 Q96DB2 3/20 0.35
HDAC8 Q9BY41 3/20 0.35
HDAC6 Q9UBN7 3/20 0.35
HDAC9 Q9UKV0 3/20 0.35
HDAC5 Q9UQL6 3/20 0.35
PDE10A Q9Y233 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
F2 P00734 2/20 0.34
PRSS1 P07477 2/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4326418 0.99 ASAH1 (0.39) ASAH1PLA2G4ACES1HDAC3HDAC4
SCHEMBL4315379 0.97 ASAH1 (0.41) ASAH1PLA2G4ACES1HDAC3HDAC4
Hydrochloric Acid SCHEMBL4326430 0.96 ASAH1 (0.40) ASAH1PLA2G4ACES1HDAC3HDAC4
SCHEMBL14129898 0.91 ALDH1A1 (0.33) ASAH1F2PRSS1ALDH1A1
SCHEMBL4322098 0.91 MCHR1 (0.35) ASAH1
Hydrochloric Acid SCHEMBL4328633 0.90 ALDH1A1 (0.33) ASAH1F2PRSS1ALDH1A1
SCHEMBL14129900 0.89 ALDH1A1 (0.36) ASAH1EGLN1F2PRSS1ALDH1A1
SCHEMBL4320660 0.89 DRD2 (0.37) KDM4E
Hydrochloric Acid SCHEMBL4331006 0.89 ALDH1A1 (0.36) ASAH1EGLN1F2PRSS1PRSS2
SCHEMBL14129926 0.88 HTT (0.35) PDE10AF2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161311-A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. 2008-07-03 US disclosed
US-20080161311-A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. 2008-07-03 US disclosed
US-7211572-B2 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2007-05-01 US disclosed
US-7211572-B2 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2007-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161311-A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor DNTT, PNP, NNMT ASAH1 2069/4885PLA2G4A 4570/4885CES1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.